Eitr Biologics
Biotechnology company developing a nanotherapeutic platform to enable single-domain antibody-based immunotherapeutics for oncology and infectious disease, with emphasis on molecules engineered for improved tissue and bacterial penetration. Headquartered in San Diego, CA.
Industries
biotechnology
clinical-trials
oncology
therapeutics
Nr. of Employees
small (1-50)
Products
Nanotherapeutic platform for single-domain antibody delivery
Platform for designing and delivering compact single-domain antibody-based therapeutics intended to improve penetration into tumors, tissues, and bacterial outer layers.
Nanotherapeutic platform for single-domain antibody delivery
Platform for designing and delivering compact single-domain antibody-based therapeutics intended to improve penetration into tumors, tissues, and bacterial outer layers.
Expertise Areas
- Antibody engineering
- Nanotherapeutics
- Oncology therapeutics
- Antibacterial therapeutics (gram-negative targets)
Key Technologies
- Single-domain antibodies
- Bispecific antibody constructs
- Nanotherapeutic delivery platforms
- Tissue-penetrating biologics